C4 Therapeutics (C4T) is a clinical-stage biotechnology company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. We are leveraging our TORPEDO® platform to rapidly and efficiently design and optimize small-molecule medicines that harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. We are advancing multiple targeted oncology programs to the clinic and expanding our research platform to deliver the next wave of medicines for difficult-to-treat diseases.